Eton Pharmaceuticals, Inc. ETON
Set alert
At close
Pre-market · Nov 2, 4:27 AM ET
- YTD
- +208.57%
- 1 year
- +185.92%
- Open
- 53.33
- Prev close
- 53.67
- Mkt cap
- 1.49B
- Vol
- 333.69K
- Avg vol
- 562.95K
- EPS
- 0.40
- P/E
- 130.45
- Div yield
- 0.00%
More statistics
- Low
- 51.89
- High
- 53.62
- Forward P/E
- 20.47
- Beta
- 0.90
- Short ratio
- 3.18
- Inst. own
- 71.64%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 56.16
- 200-d avg
- 35.52
- 1y target
- 71.50
News
3 days ago globenewswire.com
Eton Pharmaceuticals to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026
DEER PARK, Ill., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing…
1 week ago defenseworld.net
Eton Pharmaceuticals, Inc. $ETON Shares Newly Bought by Robeco Institutional Asset Management B.V.
Robeco Institutional Asset Management B.V. bought a new position in Eton Pharmaceuticals, Inc. (NASDAQ: ETON) in the undefined quarter, according to its most recent disclosure with the Securities and…
2 weeks ago benzinga.com
Eton Pharmaceuticals Lands Exclusive US Rights To Aquestive's Seizure Rescue Drug
Eton Pharmaceuticals licenses Aquestive’s LIBERVANT buccal film for U.S. seizure cluster treatment, with launch set for April 2027.
-
2 weeks ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Eton Pharmaceuticals, Maintains $70 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and maintains $70 price target.
-
2 weeks ago benzinga.com
Eton Pharmaceuticals And Aquestive Therapeutics Enter Exclusive U.S. License And Supply Agreement For LIBERVANT Buccal Film For Seizure Clusters In Patients With Epilepsy; Sees Commercial Availability In April 2027
Differentiated, portable buccal film would offer patients and caregivers an alternative to existing nasal and rectal seizure rescue treatments, a market opportunity that exceeds $450 million annually…